Burlington, MA, United States of America

Vaghefi Farid


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vaghefi Farid: Innovator in Abuse-Resistant Pharmaceutical Compositions

Introduction

Vaghefi Farid is a notable inventor based in Burlington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that are resistant to abuse. His innovative work aims to enhance the safety and efficacy of pharmaceutical products.

Latest Patents

Farid holds a patent for an "Abuse-resistant pharmaceutical composition." This invention involves a controlled release pharmaceutical composition that includes discrete particles of an active ingredient capable of abuse. The surfaces of these particles are treated with a water-insoluble coating material, making it difficult to separate the abuse-capable compound from the matrix. The method for preparing this composition involves applying pressure to a mixture of water-insoluble material and particles of a pharmaceutically active compound, resulting in surface-coated particles that are incorporated into a pharmaceutical composition.

Career Highlights

Vaghefi Farid is associated with Elan Pharma International Limited, where he continues to work on innovative pharmaceutical solutions. His expertise in creating abuse-resistant formulations has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Farid has collaborated with notable colleagues, including Gary G. Liversidge and Stephen B. Ruddy. These partnerships have contributed to the advancement of his research and the development of effective pharmaceutical compositions.

Conclusion

Vaghefi Farid's work in abuse-resistant pharmaceutical compositions showcases his commitment to improving drug safety and efficacy. His innovative contributions are essential in addressing the challenges associated with pharmaceutical abuse.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…